NONSTANDARD ABBREVIATIONS psychostimulant use disorders (PUDs) methamphetamine (MA) quantitative trait locus (QTL) substance use disorders (SUDs) DBA/2J (D2J) C57BL/6J (B6J) Hnrnph1 mutants (H1 +/-) quantitative trait variant (QTV) real-time quantitative PCR (qPCR)
Increasing methylglyoxal levels preclinically reduced alcohol drinking (18, 19) , induced a rapid antidepressantlike response (20) , and reduced seizures (21) . To summarize, mouse forward genetic studies have led to the identification and/or corroboration of several promising therapeutic targets for SUDs and other psychiatric disorders.
To fine map a QTL in which the DBA/2J (D2J) allele was associated with reduced MA-induced locomotor activity (22) , we previously employed an interval-specific congenic approach in C57BL/6J (B6J) mice carrying various introgressed regions on chromosome 11 from the DBA/2J strain (23) and detected a fortuitous recombination event that revealed a 210 kb region on chromosome 11 (50.37 -50.58 Mb) that was necessary for reduced sensitivity in the locomotor stimulant response to MA (24) . Specifically, replacement of this polymorphic region with the background C57BL/6J allele completely eliminated the MA-induced behavioral phenotype, thus demonstrating that this region was necessary for reduced MA-induced locomotor activity (24) . The 210 kb region contains two protein-coding genes -Hnrnph1 and Rufy1. Introduction of a heterozygous deletion within the first coding exon of each gene provided strong support for Hnrnph1 (and not Rufy1) as a quantitative trait gene (QTG) underlying reduced MA sensitivity (24) and we subsequently expanded the phenotypic repertoire of the Hnrnph1 mutants to include a reduction MA reinforcement, MA reward and MA-induced dopamine release (25) .
Thus far, we have only demonstrated that inheritance of the polymorphic region containing Hnrnph1 and Rufy1 was necessary for the reduction in MA-induced behavior in response to inheritance of the D2J allele within the 210 kb region. In order to demonstrate that this region is also sufficient, in the present study, we backcrossed and screened for congenic mice capturing only Hnrnph1 and Rufy1 and we identified a founder containing a 114 kb introgressed region. Following the observation of reduced MA-induced locomotor activity in 114 kb mice, we assessed their transcriptome at both the gene-and exon-level and compared these results to the transcriptome of Hnrnph1 mutants (H1 +/-) in order to provide further support for Hnrnph1 as a QTG and to identify the quantitative trait variant(s) (QTV)s. After discovering differential exon usage of the 5' UTR of Hnrnph1 in 114 kb mice as a potential molecular mechanism underlying the QTL and QTG, we validated this result via real-time quantitative PCR (qPCR) by targeting the exon junction and the specific exons. Finally, to identify the QTV(s), we cloned the 5' untranslated region (5' UTR) of Hnrnph1 containing either the individual Hnrnph1 5' UTR variants, or the combined set of the four 5' UTR variants, fused to a luciferase reporter gene and tested the effect on reporter expression in two different cell lines. The results identify a set of 5' UTR variants within Hnrnph1 that likely represent the QTVs underlying gene regulation and likely behavior.
MATERIALS AND METHODS

Generation of B6J.D2J 114 kb congenic mice
All procedures involving mice were conducted in accordance with the Guidelines for Ethical Conduct in the Care and Use of Animals and were approved by the Institutional Animal Care and Use Committee at Boston University (#AN-15326). The founder 114 kb congenic mouse was identified by monitoring the distal single nucleotide polymorphism (SNP) sites of offspring generated via backcrossing heterozygous congenic mice from Line 4a carrying one copy of a ~11 Mb introgressed interval from the D2J strain to the background B6J strain (24) . We monitored for retention of the most proximal D2J SNP that was just upstream of Hnrnph1 (rs29383600; 50,373,006 bp; mm10) and this SNP defined the proximal end of the 114 kb interval. We previously genotyped several purported SNP markers proximal to rs29833600 that were monomorphic until 49,873,463 bp (mm10), which was catalogued by Sanger as a B6J/D2J polymorphic marker and that we genotyped as homozygous for B6J (24) . As we were unable to identify any polymorphisms between 49,873,463 bp (mm10) and rs29383600, we defined the proximal interval of this smaller congenic with the marker rs29383600 (50, 373 ,006 bp). The remainder of the genome is isogenic for B6J as determined by several other markers on chromosome 11 and by a medium-density genotyping array containing 882 informative SNP markers from our previous study (24) .
We also simultaneously monitored for the detection of a recombination event (i.e., the observation of a homozygous B6J genotype) at a second marker located just distal to Rufy1 (rs254771403; 50,486,998 bp; mm10).
Following detection of a recombination event at rs254771403, we then genotyped at an additional upstream proximal marker at rs29459915 (50, 484, 260 bp; mm10) that was also downstream of Rufy1 and found retention of the D2J allele at this locus. Thus, the new remarkably smaller congenic interval was conservatively defined by a region spanning proximal rs29383600 (50,373,006 bp) and distal rs254771403 (50,486,498 bp), yielding a 114 kb interval. Thus, we named this new congenic "114 kb".
PCR primers were designed to amplify a ~200 bp amplicon that contained and flanked each SNP. The PCR products were run on a 1.5% agarose gel and visualized for band specificity. Single bands were excised according to their predicted fragment size and gel-purified (Promega Wizard SV Gel and PCR Clean-Up System, Cat A9281), and prepared for Sanger sequencing (Genewiz, Cambridge, MA, USA). Mice homozygous for the 114 kb region (referred to as 114 kb) and B6J littermates were generated via heterozygous-heterozygous 114 kb breeders. To avoid genetic drift, heterozygous 114 kb breeders were maintained by mating heterozygous male offspring with C57BL/6J females purchased from The Jackson Laboratory in Bar Harbor, ME, USA.
Homozygous 114 kb mice were generated by breeding the heterozygous breeders. Mice were SNP-genotyped using genomic DNA extracted from tail biopsies and two Taqman SNP markers: rs29383600 (50.37 Mb) and rs29459915 (50.48 Mb) (ThermoFisher Scientific, Waltham, MA, USA).
Methamphetamine (MA)-induced locomotor activity in 114 kb mice
Both female and male littermates (56-100 days old at the start of the experiment), were phenotyped for MA-induced locomotor activity. Mice were housed in same-sex groups of 2 to 4 mice per cage in standard shoebox cages and housed within ventilated racks under standard housing conditions. Colony rooms were maintained on a 12:12 h light-dark cycle. The estimated sample size required to detect a significant effect (Cohen's d = 0.72), with 80% power (p < 0.05) was n = 25 per genotype based on the previously published phenotype in the larger congenics capturing a QTL for reduced MA-induced locomotor activity (24) . Mice were tested for baseline locomotor activity on Days 1 and 2 over 60 min and then administered MA (2 mg/kg, i.p.) on Days 3, 4, and 5 and were video-recorded for distance traveled over 60 min using Anymaze (Stoelting Co., Wood Dale, IL, USA) as previously described (24) . Data are presented in six, five-min bins or as the summed distance traveled over 60 min for each of the five days of injections.
Transcriptome analysis
Striatum punches were harvested bilaterally from 114 kb mice homozygous for the congenic region (n = 8) and B6J wild-type littermates (n = 8) and processed for total RNA extractions (24) . RNA samples were bioanalyzed (RIN > 8) and cDNA library was prepared using the Illumina TruSeq Standard mRNA LT (100 bp paired-end reads). The 16 samples were multiplexed and sequenced over three lanes on Illumina HiSeq 2500. The data is available on the NCBI GEO database under accession number GSE76929. FastQ files were aligned to the mouse mm9 reference genome using TopHat (26) . HTSeq Python framework (27) was used to compute the read counts per gene followed by limma (28) to integrate counts and detect differentially expressed genes. For differential analysis, a linear model was used to compare gene expression between genotypes with "Cage" included as a covariate. Furthermore, between-technical replicate correlation was accounted for using the duplicateCorrelation(), limma function (29) .
Differential exon usage analysis
For differential usage of exons using limma (28) , reads were aligned to the Ensembl-annotated genome that contains extensive annotation of coding and non-coding exons and quantified using DEXSeq (30) with a requirement of one read count per exon bin and a minimum of at least 10 reads across all replicates. Similar to differential analysis, for each gene, a linear model was used to detect differential exon usage between genotypes with "Cage" included as a covariate and between-technical replicate correlation was accounted for using the duplicateCorrelation(), limma function (29) . Differential exon usage was defined as the proportion of total normalized reads per gene that are counted within an exon bin for that gene. Statistical significance was evaluated using gene-level tests, including an F test that reflects a consensus signal across a gene and is highly powered to detect differential exon usage when more than one signal is observed across multiple exons per gene. We also report the results form a Simes multiple testing procedure that assess all exons within a gene which is more powered to detect differential exon usage when a single strong signal is observed.
Real-time quantitative PCR (qPCR) validation
For qPCR validation of exon usage, oligo-dT primers were used to synthesize cDNA from total RNA using the same samples that were used in RNA-seq analysis using SYBR Green (ThermoFisher Scientific, Waltham, MA, USA; Cat# 4309155). The qPCR primers used for exon usage in Hnrnph1 and Ppp3ca (two of the top genes with differential exon usage) are shown in Supplementary Table 1 . Each sample was run in triplicate, averaged, and normalized to its own expression level using GAPDH as a housekeeping gene.
Differential exon usage was reported as the fold-change in 114 kb mice relative to B6J littermates using the 2 -(∆∆C T ) method (31) .
Hnrnph1:luc2 and B6J/D2J reporter lines construction
We cloned the B6J Hnrnph1 promoter sequence (Chr11: 50,375,375 to 50,378,330; mm10) starting at 2956 bp upstream of the annotated transcription start site for Hnrnph1. This sequence was amplified from B6J genomic DNA extracted from spleen tissue using iProof High-Fidelity PCR kit (BIO-RAD, Hercules, CA, USA;
Cat# 172-5330) with the following primers containing XhoI and HindIII restriction enzyme sites in the sense and antisense primers respectively: sense (5'-GATTCTCGAGGCTCCCGTGATCAGATACAG-3') and anti-sense 
Cell transfection
For HEK293T, cells were seeded in 6-well plate at a density of 2.5 x 10 5 cells per well 24 hours prior to transfection and would be about 90% confluent at the time of transfection. For N2A (given they grow faster than HEK293T cells), cells were seeded in 6-well plate at a density of 2 x 10 5 cells per well. A suspension of plasmids, Lipofectamine 3000 and P3000 reagents (ThermoFisher Scientific, Waltham, MA, USA; Cat# L3000008) in Opti-MEM medium was pre-incubated at room temperature for 15 min before being added to each well of the 6-well plates. The cells were co-transfected with 1 µg of the experimental firefly luciferase construct and 0.2 µg internal pRL control plasmid expressing Renilla luciferase driven by the CMV promoter (Promega, Madison, WI, USA;
Cat# E2261). 24 hours after transfection, HEK293T cells are detached with 0.25% of Trypsin-EDTA (ThermoFisher Scientific, Waltham, MA, USA; Cat# 25200056) and counted and re-seeded at a density of 2.5 x 10 4 cells per well in 96-well plate. N2a cells were re-seeded at a density of 2 x 10 4 cells per well in 96-well plate.
Cells were allowed to grow for approximately 48 h before measurement of luciferase activity.
Dual luciferase reporter assay
To account for background fluorescence signal, untransfected cells were used to subtract out background signal from the 96-well plate. Negative control cells were transfected with the promoter-less plasmid 
RESULTS
Positional cloning of a 114 kb interval that is necessary for reduced MA sensitivity
In backcrossing the congenic line "Line 4a" that captured a QTL for reduced MA-induced locomotor activity and contained a heterozygous introgressed region from the D2J strain that spanned 50 Mb to 60 Mb, we monitored for recombination events at rs254771403 (50,486,998 bp, mm10). We identified a crossover event that defined 114 kb congenic region that influenced MA sensitivity. There are two protein coding genes within this 114 kb region -Hnrnph1 and Rufy1 (Fig.1A) . 114 kb mice homozygous for the D2J allele within this region on an otherwise isogenic B6J background displayed no difference in saline-induced locomotor activity, compared to their wild-type homozygous B6J littermates (Fig.1B,C) . In response to an acute dose of MA on Day 3, 114 kb mice showed reduced locomotor activity relative to B6J (Fig.1D) . Again, in response to a second dose of MA on Day 4, the 114 kb mice showed a decrease in MA-induced locomotion, compared to wild-type B6J littermates ( Fig.1E ). No genotypic difference in MA-induced locomotor activity were observed on Day 5 after the third MA injection (Fig.1F ). Both 114 kb and B6J mice showed habituation to the testing apparatus as indicated by a reduction in saline-induced locomotor activity from Day 1 to Day 2 (Fig.1G ). Relative to the B6J mice, the 114 kb mice showed greater sensitization to repeated doses of MA from Day 3 to Day 5 (Fig.1G) . In comparing summed locomotor activity over 60 min across the five days, the 114 kb mice showed a significant reduction in MA-induced locomotor activity compared to B6J wild-type littermates on Day 4 (Fig.1G) . Taken together, these results indicate that 114 kb mice are less sensitive to the locomotor stimulant response to MA.
Normalized MA-induced locomotor activity, as well as MA-induced locomotor sensitization, in 114 kb mice
Next, we examined MA-induced locomotor activity while accounting for individual differences in baseline locomotion in response to saline on Day 2, as well as MA-induced locomotor sensitization, via differences in MA-induced locomotor activity between MA treatment days. When accounting for non-drug locomotor activity, we again found that 114 kb mice showed less acute MA-induced locomotor activity relative to B6J mice ( Fig.2A) , as well as after repeated exposure to MA ( Fig.2B-C) . After two MA injections (comparing Day 4 versus Day 3 activity), 114 kb mice showed a significant decrease in locomotor sensitization early postinjection ( Fig.2D ). After three MA injections (comparing between Day 5 and Day 3), 114 kb mice showed a significant increase in locomotor sensitization, starting at 20 min post-MA ( Fig.2E) . Again, when comparing Day 5 versus Day 4, 114 kb mice also showed significantly greater MA locomotor sensitization relative to B6J mice ( Fig.2F ). The greater sensitization in 114 kb mice is likely due to their initially lower MA response.
Transcriptome analysis identifies differential 5' UTR exon usage of Ppp3ca as well as Hnrnph1 in 114 kb mice
To further understand the molecular mechanism of the 114 kb congenic region in reducing MA sensitivity, we performed both differential gene expression and differential exon usage analysis on RNA-seq data collected from the striatum of naïve 114 kb and their B6J wild-type littermates. We identified 69 differentially expressed genes (p < 0.001; Table 1 ) and 35 genes exhibiting differential exon usage (Table 2A, B) , which is defined as the proportion of total normalized reads per gene that are counted within an exon bin for that gene. Notably, Hnrnph1 (the first protein-coding gene within the 114 kb congenic interval) was one of the top genes exhibiting differential exon usage, providing direct evidence at the exon level for one or more functional variants within the gene that regulates exon usage and ultimately underlies differences in behavior. It should also be noted that we did not identify any significant difference in gene expression or in exon usage of Rufy1 (the second protein-coding gene within the interval), thus limiting functional effects of D2J variants at the transcript and exon level to
Hnrnph1 and further supporting the candidacy of Hnrnph1 as a quantitative trait gene underlying MA behavior (24) .
We previously showed that mice heterozygous for a 16-bp deletion within the first coding exon of Hnrnph1 (refer to as the H1 +/mice) were less sensitive to the stimulant, rewarding, and reinforcing properties of MA and showed a reduction in MA-induced dopamine release (24, 25) . To directly compare the functional effects of inheriting the deletion versus the 114 kb congenic region on gene expression and exon usage, we identified 21
overlapping genes that were differentially expressed in the striatum between 114 kb mice and H1 +/mice relative to their B6J wild-type littermates (Fig.3A) , which was significantly greater than what would be expected by chance (Fisher's exact test: p = 9.31 x 10 -23 ). In addition, there were 10 overlapping genes between H1 +/and 114 kb mice that showed differential exon usage, relative to their B6J littermates (Fig.3B) . This, again, was significantly greater than what would be expected by chance (Fisher's exact test: p = 2.96 x 10 -07 ). Finally, in correlating differential expression for the 21 shared differentially expressed genes between 114 kb mice and H1 +/mice, we found a nearly perfect relationship between the magnitude and direction of change in gene expression (Table 3 and Fig.4 ). These results suggest functionally similar effects of the 114 kb region and the H1 +/allele on their overlapping, convergent transcriptome.
Ppp3ca (or calcineurin A subunit gene) was identified as the top gene with differential exon usage in the 114 kb mice, relative to B6J wild-type littermates ( Table 2) and it was also one of the 10 overlapping genes with differential exon usage (Fig.3B ). Fine mapping of PPP3CA reveals novel alternative splicing patterns in human subjects with high addiction vulnerability (32) . In order to validate differential exon usage in Ppp3ca in the 114 kb mice, we designed primers flanking exons to detect the splicing isoforms of PPP3CA identified by Chiocco et al. (32) (Fig.5A ; Supplemental Table 1 ). 114 kb mice showed greater usage of exons 1 to 2 but no difference in the other 6 exon junctions (Fig.5A) . To further investigate the specific exon, we designed primers to target exons 1 and 2 separately. Relative to B6J, increased exon 1 usage was shown in the 114 kb mice (Fig.5B) , with no difference in exon 2 usage (Fig.5C ). Exon 1 is part of the 5' UTR of Ppp3ca. Thus, we conclude that the 114 kb mice show an increased number of transcripts that include this 5' UTR exon.
The physical positions and exon numbers comprising differential exon usage of Hnrnph1 in 114 kb relative to B6J mice are shown in Table 4 . Note that fewer normalized reads were mapped to the junction comprising exons 3 and exon 4 in 114 kb mice versus B6J. Additionally, a greater number of normalized reads mapped to the junction comprising exons 6 and 7, as well as the junction comprising exons 7 and 8 in the 114 kb mice relative to B6J (Table 4 ). It is important to note that Hnrnph2 (homolog of Hnrnph1) did not show differential exon usage in our analysis. To validate differential exon usage of Hnrnph1, we performed qPCR with primers flanking those exons with significant differential exon usage. Out of the three exon junctions, 114 kb mice showed less usage of exons 3 to 4, but no difference in the other two exon junctions (Fig.6A) . To further validate the specific exons exhibiting differential usage, we designed primers to target exon 3 and exon 4
separately. Less usage of exon 3 was detected in the 114 kb mice (Fig.6B) , with no change in exon 4 (Fig.6C) .
Exons 1 to 3 are part of the 5' UTR of Hnrnph1 (Fig.7) . Thus, we conclude that 114 kb mice show a reduced number of Hnrnph1 transcripts that include this 5' UTR exon.
Identification of a set of 5' UTR functional variants in Hnrnph1 that decrease luciferase reporter expression
To identify potential functional variants in the 5' UTR of Hnrnph1 underlying MA-induced behavior, we used the whole genome sequence dataset (33, 34) and the online Sanger variant query tool (https://www.sanger.ac.uk/sanger/Mouse_SnpViewer/rel-1505) to identify three SNPs and one indel (insertion/deletion) that were located within the 5' UTR exons and introns (Table 5 ; highlighted in orange).
There are 12 additional Hnrnph1 variants downstream of the 5' UTR ( Table 5 and Fig.7) . Given that the 5' UTR contains a promoter element for transcriptional regulation, we employed a luciferase reporter system to assay the function of the Hnrnph1 promoter in both Human Embryonic Kidney (HEK) 293T and Neuro2a (N2a) cells.
Using this system combined with site-directed mutagenesis, we examined the effect of each of the four 5' UTR Hnrnph1 variants on Hnrnph1 promoter activity. To examine Hnrnph1 promoter activity, we developed a Fig.1 and 2A, and Fig.8A) . We next tested whether this cloned promoter could drive expression of the firefly luciferase gene, luc2. The 2956-bp promoter increased firefly luminescence compared to the pGL4.17[luc2/Neo] vector, and this increase in signal showed a dose-dependency, depending on the number of plated cells (Supplemental Fig.2B ).
Using site-directed mutagenesis, we constructed 4 Hnrnph1 promoters each possessing its own D2J variant within the 5' UTR (Supplemental Table 2 ). In HEK293T cells, none of the four promoters with a single D2J variant differed significantly from the B6J Hnrnph1 promoter with regard to driving luciferase expression ( Fig.8B) . However, when all four D2J variants were introduced into the promoter, there was a significant reduction in luciferase activity compared to the B6J promoter (Fig.8C) . The findings were subsequently replicated in N2a cells (Fig.8D-E) . Taken together, these results identify a set of functional 5' UTR variants within Hnrnph1 that decrease exon 3 usage of Hnrnph1 and reduce Hnrnph1-promoter driven transcription.
DISCUSSION
The 114 kb region containing two protein genes (Hnrnph1, Rufy1) was not only necessary (24) , but was also sufficient, to induce a decrease in sensitivity to the locomotor stimulant response to MA (Fig.1) . Our prior work strongly implicated Hnrnph1 and not Rufy1 as the QTG responsible for the reduction in MA-induced locomotor activity (24) and we subsequently expanded the behavioral repertoire of H1 +/mice to include reduced MA-induced reinforcement, reward, and dopamine release (25) . Our exon-level transcriptome analysis and comparative differential gene expression analysis between the 114 kb congenics and H1 +/mice further supports
Hnrnph1 as the QTG underlying the reduction in MA-induced behavior (Fig.3) . Specifically, we found differential exon usage of the 5' UTR of Hnrnph1 in 114 kb mice that was independently validated via qPCR ( Fig.6) and was associated with the inheritance of four SNP/indel variants near the 5' UTR as demonstrated by a reporter assay to measure Hnrnph1 promoter strength (Fig.8) . (38), Grm2 (13), and Taar1 (39) . With regard to Hnrnph1, a human candidate gene association study identified a functional intronic variant in OPRM1 (mRNA target of hnRNP H) affects binding to hnRNP H to regulate splicing that was associated with the severity of heroin addiction (40) .
Identification of QTGs and
We identified a set of four D2J variants within the 5' UTR of Hnrnph1 and its introns that were associated with differential 5' UTR exon usage (Fig.6 ) and decreased transcription (Fig.8) . A reasonable assumption is that inheritance of these 5' UTR variants is also sufficient to decrease hnRNP H1 protein expression, however, direct demonstration would require cloning of the full-length gene plus a reporter tag since there are currently no selective antibodies that can distinguish hnRNP H1 from hnRNP H2. At the exon-level, we validated a decrease in Hnrnph1 transcripts containing exon 3 (Fig.6B) . The decrease in reporter expression was observed in our in vitro assays comprising two different cell lines, despite the fact that we did not observe any significant gene-level change in Hnrnph1 transcription in 114 kb mice carrying these 4 variants [plus the 12 other additional variants; log2FC = 0.016; t(14) = 0.70; p = 0.49]. Together, these results indicate that D2J variants within and surrounding the 5' UTR of Hnrnph1 leads to exclusion of exon 3, which in turn leads to a functional decrease in protein translation. These variants may also cause other functional changes in the 5' UTR leading to a decrease in protein translation by modifying the regulatory elements within the promoter to reduce efficacy of translation (40) , or changing the binding sites for other RNA-binding proteins (RBPs) to repress initiation of translation (41, 42) .
The top gene demonstrating differential exon usage in 114 kb mice was Ppp3ca (Table 2, Fig.3) , a gene coding for the alpha catalytic subunit of calcineurin (a.k.a. PP2B), a Ca 2+ -responsive serine/threonine protein phosphatase that regulates dopamine and excitatory signaling, as well as the behavioral response to psychostimulants (43) . We independently validated our result via qPCR by showing an increase in transcription of exon 1 of Ppp3ca, which is a 5' UTR exon (Fig.5) . A human genetic fine mapping study identified a trinucleotide repeat in the 5' UTR of PPP3CA that showed allele-specific expression and altered expression of novel, alternatively spliced isoforms that were associated with addiction vulnerability and Alzheimer's disease (32) . These 5' UTR variants were associated with the production of splice variants with predicted functional alterations as the coding sequences lack portions of the catalytic and/or regulatory subunits (32) . Another study using convergent functional genomic analysis of transcriptome and GWAS datasets of cocaine addiction traits identified PPP3CA as one of the top genes (44) . Other genetic studies found de novo mutations in PPP3CA that cause severe neurodevelopmental disorders and seizures (45) . We hypothesized that more subtle genetic mutations in RNA-binding proteins could alter the neurodevelopment of the reward circuitry and processing that, in an amoeba species that Ppp31 (protein phosphatase 3 regulatory subunit B, alpha), a gene coding for one of the Ca 2+ -binding regulatory subunits of calcineurin, shows expression of two different isoforms at the mRNA and protein level and their mass sizes correspond to two different alternative start codons. The smaller sized transcript lacked the 5' UTR and the more upstream start codon, thus demonstrating differential 5' UTR usage of this subunit (47) . Calcineurin dephosphorylates residues of various dopamine signaling molecules that are phosphorylated by kinase cascades in response to D1 dopamine receptor activation (e.g., PKA, casein kinase I),
including DARPP-32 (48, 49) and has been implicated in a variety of MA effects, including MA-induced locomotor sensitization (50-52), destabilization of contextual memory (53), apoptosis (54) , and neurotoxicity (55) . In addition to dephosphorylation in dopamine receptor signaling, mitochondrial dysfunction can initiate a stress response that activates calcineurin and the RNA-binding protein hnRNPA2 that acts as a coactivator to regulate transcription of nuclear target genes (56, 57) . hnRNP H binds exon 2 of the mitochondrial gene Ndufb11 and regulates alternative splicing (58) . We previously conducted synaptosomal proteomic analysis and found indirect evidence for mitochondrial dysfunction in H1 +/mice at baseline and in response to MA, including changes in complex I and V proteins (25) . We propose that Hnrnph1 D2J polymorphisms decrease transcription of Hnrnph1 (Fig.6) , preventing the binding and subsequently exon 1 exclusion of Ppp3ca (Fig.5) . To summarize, we provide further causal behavioral and molecular evidence for Hnrnph1 as a QTG for MA sensitivity by demonstrating that inheritance of a very small, 114 kb chromosomal region was not only necessary (24) but also sufficient to induce the behavioral phenotype. We provide functional evidence for a set of four QTVs within the 5' UTR that plausibly regulate differential exon usage and gene expression. The functional significance of these variants at the behavioral level is unknown but our comparative transcriptome analysis of the 114 kb mice with the H1 +/mice (24, 25) demonstrates functionally similar genotypic effects on the degree and direction of fold-change in gene expression and behavioral response to MA. We predict that inheritance of these 5' UTR variants in Hnrnph1 alone would also be sufficient to induce a functional effect at the behavioral level. However, the subtle effect of the 114 kb region on behavior raises the question of whether modeling these variants in vivo is worth the effort -convergent evidence provides strong evidence that we have identified the QTVs underlying functional molecular and behavioral changes. Finally, we identified Ppp3ca as a candidate RNA-binding target of hnRNP H1 that could bridge Hnrnph1 polymorphisms and function with methamphetamine-induced dopaminergic signaling mechanism(s) underlying addiction-relevant behaviors (25) . traveled is shown to indicate which genotype continued to sensitize, even after two MA injections. Again, 114 kb mice showed increased locomotor sensitization relative to B6J [mixed ANOVA: F(1,46)Genotype = 8.50, p = 0.006; F(11,506)Genotype x Time = 1.75, p = 0.061; unpaired t-test for each 5-min bin: t(48)5min = 2.67, *p = 0.010; t(48)15min = 3.28, *p = 0.002; t(48)20min = 4.59, *p = 3.17E-05; t(48)25min = 3.43, *p = 0.001; t(48)35min = 2.24, *p = 0.030]. No main effect of Sex was detected for any locomotor sensitization measures (panels A-F) B6J. (A -B) : The table shows genes exhibiting differential exon usage in striatal tissue from 114 kb mice vs. their B6J wild-type littermates.
Differential exon usage was detected using either an F-test (A) or a Simes test (B) in limma. overlapping genes with differential exon usage in 114 kb mice (p < 0.001) versus H1 +/mice (p < 0.001). Ten genes showed differential exon usage in both the 114 kb mice and the H1+/-mice which is significantly greater than chance (Fisher's exact test: p = 2.96E-07) and include Ppp3ca, Cdhr4, Hnrnph1, Mapk9, Hnrnpm, Ptpn5, Ip6k1, Uba7, Slc8a3, and Mtap4. within an exon bin between the 114 kb versus B6J wild-type littermates. Exon usage was defined as the proportion of total normalized reads per gene that are counted within an exon bin for that gene. To validate differential exon usage, we designed a set of qPCR primers based on differential PPP3CA isoform expression identified in substance-dependent human subjects (32) . The primer sequences are provided in Supplemental Table 1 
. (A): Out
of the seven exon junctions tested, 114 kb mice showed increased usage of the first 5' UTR exon junction, namely exon 1-2 [unpaired t-test for each exon junction: t(13)exon 1-2 = 2.67, *p = 0.003; t(13)exon 1-3 = 0.23, p = 0.825; t(6)exon 1-11 = 0.12, p = 0.813; t(6)exon 2-9 = 1.31, p = 0.248; t(6)exon 8-10 = 1.05, p = 0.340; t(13)exon 12-13 = 0.47, p = 0.645; t(13)exon 12-14 = 1.77, p = 0.100]. (B-C): To further test specific exons, primers targeting either exon 1 or 2 of Ppp3ca were used to demonstrate that 114 kb mice showed increased usage of exon 1 [unpaired t-test: t(13) = 2.73, *p = 0.017] but no difference in exon 2 [unpaired t-test: t(13) = 1.16, p = 0.268]. Bars and error bars are represented as mean ± SEM. Figure 6 
